LivaNova PLC
LivaNova PLC (LIVN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LIVN · as of Jun 8, 2026
Key Statistics
Explore LivaNova PLC Data
livn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 71.4%
The LIVN analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $79.25, representing +9.52% upside from the current price of $72.36.
Competitors & Peers
livn competitorsLIVN
ATEC
CDTX
HTFL
IDYA
IRONStock Performance
Full HistoryAbout LivaNova PLC
LivaNova PLC a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced C…
what is livanova plc · livn stock overview · livanova plc company profile · who is livanova plc ceo · livn NASDAQ · livanova plc headquarters · livanova plc business segments
About Stock Overview & Key Data
LivaNova PLC (LIVN) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 19, 2015. As of the latest trading session, LIVN stock price is $72.36, with a market capitalization of $4.0B. The stock has returned +56.29% over the past 12 months and +17.60% year-to-date.
According to 14 Wall Street analysts, the consensus rating for LivaNova PLC stock is Buy, with an average 12-month price target of $79.25. In fiscal year 2025, LivaNova PLC reported revenue of $1.4B and net income of -$242.5M. For detailed data — including LivaNova PLC revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LivaNova PLC (LIVN) stock price is $72.36. The stock is traded on NASDAQ under the ticker symbol LIVN. The 52-week range is $41.02 – $75.81.